• FOLLOW US
Video Player
  • Email
  • share

Sanofi to Pay MannKind as Much as $925M for Afrezza Global Rights

Sanofi said it will pay MannKind as much as $925 million for the global rights to inhaled insulin Afrezza, just a couple months after the treatment received FDA approval. Afrezza is the world's only inhaled insulin, an alternative to injections for a

http://www.wgrz.com/video/3725390295001/1/Sanofi-to-Pay-MannKind-as-Much-as-925M-for-Afrezza-Global-Rights http://cdn.newslook.com/67/67b069702c33484b208b376a080134a7/images/frame_ext.jpg Sanofi to Pay MannKind as Much as $925M for Afrezza Global Rights Sanofi said it will pay MannKind as much as $925 million for the global rights to inhaled insulin Afrezza, just a couple months after the treatment received FDA approval. Afrezza is the world's only inhaled insulin, an alternative to injections for a FinanceSanofi-Aventis S.A.youtubeYahoo!newslookSASY 01:08

Next Up

    

More Videos

Recent Videos

Page 1 of 7